Profile
Full Name
BioMarin Pharmaceutical Inc.Ticker
NASDAQ: BMRNExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
July 26, 1999Indexes
Not includedWebsite
http://www.biomarin.comEmployees
3040Key Details
Price
$58.81(+1.00%)
Market cap
$11.28B(Large cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
$2.85B(+17.97% YoY)
Annual EPS
$2.21(+154.02% YoY)
PE ratio
21.86
Next earnings date
Aug 4, 2025Next ex-dividend date
N/ANext split date
N/AQuick Search
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Analyst ratings
Price
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
BioMarin Pharmaceutical Inc. doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Jul 22, 25 Morgan Stanley
OverweightJul 14, 25 JP Morgan
OverweightMay 5, 25 Goldman Sachs
BuyMay 2, 25 Citigroup
NeutralFeb 24, 25 Oppenheimer
OutperformFeb 20, 25 UBS
BuyFeb 20, 25 Scotiabank
Sector PerformFeb 20, 25 RBC Capital
Sector PerformFeb 20, 25 Piper Sandler
OverweightFeb 20, 25 Citigroup
NeutralInstitutional Ownership
- What is the ticker symbol for BioMarin Pharmaceutical Inc.?
- Does BioMarin Pharmaceutical Inc. pay dividends?
- What sector is BioMarin Pharmaceutical Inc. in?
- What industry is BioMarin Pharmaceutical Inc. in?
- What country is BioMarin Pharmaceutical Inc. based in?
- When did BioMarin Pharmaceutical Inc. go public?
- Is BioMarin Pharmaceutical Inc. in the S&P 500?
- Is BioMarin Pharmaceutical Inc. in the NASDAQ 100?
- Is BioMarin Pharmaceutical Inc. in the Dow Jones?
- When was BioMarin Pharmaceutical Inc.'s last earnings report?
- When does BioMarin Pharmaceutical Inc. report earnings?
What is the ticker symbol for BioMarin Pharmaceutical Inc.?
The ticker symbol for BioMarin Pharmaceutical Inc. is NASDAQ:BMRN
Does BioMarin Pharmaceutical Inc. pay dividends?
No, BioMarin Pharmaceutical Inc. does not pay dividends
What sector is BioMarin Pharmaceutical Inc. in?
BioMarin Pharmaceutical Inc. is in the Healthcare sector
What industry is BioMarin Pharmaceutical Inc. in?
BioMarin Pharmaceutical Inc. is in the Biotechnology industry
What country is BioMarin Pharmaceutical Inc. based in?
BioMarin Pharmaceutical Inc. is headquartered in United States
When did BioMarin Pharmaceutical Inc. go public?
BioMarin Pharmaceutical Inc.'s initial public offering (IPO) was on July 26, 1999
Is BioMarin Pharmaceutical Inc. in the S&P 500?
No, BioMarin Pharmaceutical Inc. is not included in the S&P 500 index
Is BioMarin Pharmaceutical Inc. in the NASDAQ 100?
No, BioMarin Pharmaceutical Inc. is not included in the NASDAQ 100 index
Is BioMarin Pharmaceutical Inc. in the Dow Jones?
No, BioMarin Pharmaceutical Inc. is not included in the Dow Jones index
When was BioMarin Pharmaceutical Inc.'s last earnings report?
BioMarin Pharmaceutical Inc.'s most recent earnings report was on May 1, 2025
When does BioMarin Pharmaceutical Inc. report earnings?
The next expected earnings date for BioMarin Pharmaceutical Inc. is August 4, 2025